Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
9.37
+0.35 (3.88%)
At close: Jul 9, 2025, 4:00 PM
9.11
-0.26 (-2.77%)
After-hours: Jul 9, 2025, 7:16 PM EDT
Phathom Pharmaceuticals Employees
Phathom Pharmaceuticals had 427 employees as of December 31, 2024. The number of employees decreased by 25 or -5.53% compared to the previous year.
Employees
427
Change (1Y)
-25
Growth (1Y)
-5.53%
Revenue / Employee
$191,707
Profits / Employee
-$809,813
Market Cap
652.60M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PHAT News
- 14 days ago - Phathom Pharmaceuticals: Potential Blockbuster Gastric Acid-Reducing Drug With New Mechanism - Seeking Alpha
- 16 days ago - Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 16 days ago - Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary - GlobeNewsWire
- 23 days ago - Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032 - GlobeNewsWire
- 4 weeks ago - Tiny Phathom Pharmaceuticals Just An Got FDA Blessing And Big-Time Upside: Buy - Seeking Alpha
- 4 weeks ago - Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032 - GlobeNewsWire
- 7 weeks ago - Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Phathom Pharmaceuticals, Inc. (PHAT) Q1 2025 Earnings Call Transcript - Seeking Alpha